189
Views
15
CrossRef citations to date
0
Altmetric
Clinical Focus: Hospital Admissions, Latest Protocols, Perioperative Medicine, and Transitions of Care

Summary of Clinical Practice Guidelines for Acute Kidney Injury

, MD, , MD, FACP & , MD, FACP, FASN, FCCM

References

  • . Wang HE, Muntner P, Chertow GM, Warnock DG. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 2012;35(4):349–355
  • . Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370
  • . Shihab FS. Preconditioning: from experimental findings to novel therapies in acute kidney injury. Minerva Urol Nefrol. 2009;61(3):143–157
  • . Jo SK, Rosner MH, Okusa MD. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol. 2007;2(2):356–365
  • . Han X, Zhao L, Lu G, . Improving outcomes of acute kidney injury using mouse renal progenitor cells alone or in combination with erythropoietin or suramin. Stem Cell Res Ther. 2013;4:74
  • . Clark E, Wald R, Walsh M, Bagshaw SM, Canadian Acute Kidney Injury (CANAKI) Investigators. Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant. 2012;27(7):2761–2767
  • . Uchino S, Bellomo R, Morimatsu H, . Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009;37(9):2576–2582
  • . Brochard L, Abroug F, Brenner M, ; ATS/ERS/ESICM/SRLF Ad Hoc Committee on Acute Renal Failure. An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med. 2010;181(10):1128–1155
  • . Lewington A, Kanagasundaram S. Renal Association Clinical Practice Guidelines on acute kidney injury. Nephron Clin Pract. 2011;118( Suppl 1):c349–c390
  • . KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. 2012;2(1):1–138
  • . Excellence NHaC. Acute kidney injury: Prevention, detection, and management up to the point of renal replacement therapy. London: National Institute for Health and Care Excellence, 2013
  • . 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123(18):2022–2060
  • . Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Workgroup. Acute renal failure — definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212
  • . Mehta RL, Kellum JA, Shah SV, ; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31
  • . Srisawat N, Hoste EE, Kellum JA. Modern classification of acute kidney injury. Blood Purif. 2010;29(3):300–307
  • . Gottlieb RH, Weinberg EP, Rubens DJ, Monk RD, Grossman EB. Renal sonography: can it be used more selectively in the setting of an elevated serum creatinine level? Am J Kidney Dis. 1997;29(3):362–367
  • . Ritchie WW, Vick CW, Glocheski SK, Cook DE. Evaluation of azotemic patients: diagnostic yield of initial US examination. Radiology. 1988;167(1):245–247
  • . Licurse A, Kim MC, Dziura J, . Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework. Arch Intern Med. 2010;170(21):1900–1907
  • . Podoll A, Walther C, Finkel K. Clinical utility of gray scale renal ultrasound in acute kidney injury. BMC Nephrol. 2013;14:188
  • . Haase N, Perner A, Hennings LI, . Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839
  • . Zarychanski R, Abou-Setta AM, Turgeon AF, . Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678–688
  • . Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566–1572
  • . Dellinger RP, Levy MM, Rhodes A, ; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637
  • . Cuthbertson BH, Noble DW. Dopamine in oliguria. BMJ. 1997;314(7082):690–691
  • . Kapoor A, Sinha N, Sharma RK, . Use of dopamine in the prevention of contrast induced acute renal failure. Int J Cardiol. 1996;53(3):233–236
  • . Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356(9248):2139–2143
  • . Lauschke A, Teichgraber UK, Frei U, Eckardt KU. ‘Low-dose’ dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69(9):1669–1674
  • . Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002;28(7):877–883
  • . Murray PT. Fenoldopam: renal-dose dopamine redux? Crit Care Med. 2006;34(3):910–911
  • . Cogliati AA, Vellutini R, Nardini A, . Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth. 2007;21(6):847–850
  • . Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis. 2005;46(1):26–34
  • . Stone GW, McCullough PA, Tumlin JA, ; CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290(17):2284–2291
  • . McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51(15):1419–1428
  • . Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148(4):284–294
  • . ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation. 2011;124(11):1250–1259
  • . Marenzi G, Lauri G, Campodonico J, . Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med. 2006;119(2):155–162
  • . Marenzi G, Marana I, Lauri G, . The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349(14):1333–1340
  • . Deray G. Dialysis and iodinated contrast media. Kidney Int. 2006;100( Suppl):S25–S29
  • . Vogt B, Ferrari P, Schonholzer C, . Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med. 2001;111(9):692–698
  • . Ludens JH, Hook JB, Brody MJ, Williamson HE. Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther. 1968;163(2):456–460
  • . Ludens JH, Williamson HE. Effect of furosemide on renal blood flow in the conscious dog. Proc Soc Exp Biol Med. 1970;133(2):513–515
  • . Mehta RL, Pascual MT, Soroko S, Chertow GM; PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288(20):2547–2553
  • . Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11(1):97–104
  • . Lombardi R, Ferreiro A, Servetto C. Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail. 2003;25(5):775–786
  • . Ying WZ, Sanders PW. Dietary salt modulates renal production of transforming growth factor-beta in rats. Am J Physiol. 1998;274(4 Pt 2):F635–F641
  • . Shilliday I, Allison ME. Diuretics in acute renal failure. Ren Fail. 1994;16(1):3–17
  • . Majdumdar SR, Kjellstrand CM. Why do we use diuretics in acute renal failure? Semin Dial. 1996;9(6):454–459
  • . Chen HH, Anstrom KJ, Givertz MM, ; for the NHLBI Heart Failure Clinical Research Network. Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial [published online ahead of print November 18, 2013]. JAMA. doi:10.1001/jama.2013.282190
  • . Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30(10):2205–2211
  • . Liu KD, Himmelfarb J, Paganini E, . Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1(5):915–919
  • . Elahi MM, Lim MY, Joseph RN, Dhannapuneni RR, Spyt TJ. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg. 2004;26(5):1027–1031
  • . Demirkilic U, Kuralay E, Yenicesu M, . Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg. 2004;19(1):17–20
  • . Bagshaw SM, Uchino S, Bellomo R, ; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009;24(1):129–140
  • . Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007;(3):CD003773
  • . Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med. 2008;36(2):610–617
  • . Bagshaw SM, Peets AD, Hameed M, Boiteau PJ, Laupland KB, Doig CJ. Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure—a case report. BMC Nephrol. 2004;5:9
  • . Lin CM, Lin JW, Tsai JT, . Intracranial pressure fluctuation during hemodialysis in renal failure patients with intracranial hemorrhage. Acta Neurochir Suppl. 2008;101:141–144
  • . Ronco C, Bellomo R, Homel P, . Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356(9223):26–30
  • . Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008;19(6):1233–1238
  • . Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346(5):305–310
  • . , VA/NIH Acute Renal Failure Trial NetworkPalevsky PM, Zhang JH, O'Connor TZ, . Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20
  • . Palevsky PM, Liu KD, Brophy PD, . KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649–672
  • . James M, Bouchard J, Ho J, . Canadian society of nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):673–685

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.